Tabula Rasa HealthCare, Inc.
TRHC · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.14 | 0.08 | 0.06 | -0.01 |
| FCF Yield | -0.09% | -8.47% | -5.06% | -4.81% |
| EV / EBITDA | -146.73 | 457.69 | -213.81 | -19.29 |
| Quality | ||||
| ROIC | -3.45% | -1.98% | -3.09% | -7.65% |
| Gross Margin | 25.02% | 23.51% | 23.81% | 21.88% |
| Cash Conversion Ratio | -0.52 | 0.55 | 0.08 | -0.02 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.32% | 2.13% | 0.26% | 1.02% |
| Free Cash Flow Growth | 98.44% | -91.30% | -11.09% | -137.02% |
| Safety | ||||
| Net Debt / EBITDA | -83.06 | 300.20 | -146.05 | -13.24 |
| Interest Coverage | -7.90 | -4.19 | -5.49 | -8.70 |
| Efficiency | ||||
| Inventory Turnover | 7.80 | 9.14 | 9.60 | 10.50 |
| Cash Conversion Cycle | 22.59 | 18.45 | 20.36 | 48.42 |